Summary
BlackRock Health Sciences Opportunities Portfolio Service Shares is a mutual fund run by BlackRock. It does not trade on an exchange: you buy it from the fund company at a price set once a day. Positions inside: 138. The ten largest make up 55% of the fund.
- Yearly costs
- 1.16%
- Fund size
- $6.59B
- Positions
- 138
- Dividend yield
- 13.77%
- Running since
- 2005
What speaks for it
- A large fund with $6.59B under management.
- It has been running since 2005.
What to watch
- The ten largest positions make up 55% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- Costs of 1.16% a year are above the middle of comparable funds (0.40%).
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +8.7%
- 3 months
- +9.3%
- This year
- +8.0%
- 1 year
- +8.1%
- 3 years
- +13%
- 5 years
- -10%
- 10 years
- +48%
- Avg. market cap
- $242.4B
- P/E
- 39.4x
- Forward P/E
- -
- P/S
- 2.6x
- P/B
- 5.9x
- P/FCF
- 26.1x
- EV/EBITDA
- 21.9x
- Dividend yield
- 0.95%
- ROIC
- 5.8%
- ROE
- 17.8%
- Gross margin
- 66.8%
- Operating margin
- -55.5%
- Net margin
- -28.4%
- Payout ratio
- 37.6%
- Net debt/EBITDA
- 2.1x
- Beta
- 0.49
Weighted average of the 50 largest companies, which make up 71% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 ELI LILLY 12%
- 2 JNJohnson & Johnson JNJ.TO 8.1%
- 3 MRMerck & Co. MRK 5.6%
- 4 ABAbbVie Inc. ABBV.BA 5.3%
- 5 TMThermo Fisher Scientific Inc. TMO.TO 4.9%
- 6 GIGilead Sciences, Inc. GILD.TO 4.2%
- 7 AMAmgen AMGN 4.0%
- 8 UNUnitedHealth Group Incorporated UNH.BA 3.9%
- 9 DANAHER 3.5%
- 10 VRVertex Pharmaceuticals VRTX 3.3%
Positions in the fund: 138. The ten largest make up 55% of it.
Composition as of Nov 7, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 72%
- Netherlands 1.5%
- Israel 1.4%
- Switzerland 1.1%
- Other countries 24%
By company size
- Mega cap 49%
- Large cap 42%
- Mid cap 7.0%
- Small cap 2.4%
- Micro cap 0.2%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 75% of the fund.
Largest sector: Healthcare (100%). Largest country: United States (72%). Largest size group: Mega cap (49%).
What does it cost me?
Expensive- A year from $10,000
- $116
- Over 20 years
- $5,286
From every $10,000 invested the fund takes $116 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $5,286.
How has it done?
Growing slowly- A year on average, 10 years
- +4.0%
- Deepest drop
- -30%
- Yearly volatility
- 21%
Average yearly growth over the last ten years: 4.0%. Deepest drop in these years: 30% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 13.77%
- Payments a year
- 1
- Last payment
- $6.46
Over the last 12 months it paid $9.48 per share, which is 13.77% of today's price. The last payment was $6.46 on Jul 22, 2026.
How expensive are the companies inside?
Rather expensive- P/E of the companies inside
- 39.4
- Average Bulios Score
- 51 out of 100
Weight by Bulios Fair Price
- Undervalued 15%
- Fairly valued 24%
- Overvalued 61%
On average the companies inside trade for 39.4 times their yearly profit. By Fair Price, 61% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 71% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Can I buy it as an ETF?
A mutual fund is bought from the fund company. These ETFs hold much of the same and trade on an exchange, so an ordinary broker carries them.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
PB PBPH Portfolio Building Block World Pharma and Biotech Index ETF | United States | 0.13% | $13.6M | - | - | 34% |
BM BMED iShares Health Innovation Active ETF | United States | 0.77% | $14.5M | +31% | Pays out | 26% |
VH VHT Vanguard Health Care ETF | United States | 0.09% | $18.6B | +27% | Pays out | 25% |
FH FHLC Fidelity MSCI Health Care Index ETF | United States | 0.08% | $3.95B | +27% | Pays out | 24% |
IY IYH iShares U.S. Healthcare ETF | United States | 0.37% | $4.72B | +28% | Pays out | 24% |
ZP ZPDH.DE State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) | Ireland | 0.15% | $648.2M | +34% | Reinvests | 23% |